Literature DB >> 15728984

Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas.

Dursun Mehmet1, Ertem Meliksah, Yilmaz Serif, Saka Gunay, Ozekinci Tuncer, Simsek Zeynep.   

Abstract

Although hepatitis B has been well studied, there are still aspects of its epidemiology that remain to be clarified. There are many regions with high seroprevalence, particularly in the developing regions of the world, and these regions are known to have different epidemiologic patterns. Nonetheless, there are currently no data on the differences in hepatitis B seroprevalence between urban and rural areas of Turkey. In the present study, therefore, we used 30-cluster sampling to determine and compare the prevalence of hepatitis B in the urban and rural areas of the least developed region of Turkey, the southeastern region. From 2,888 adults living in the region, blood samples were obtained from house visits, and screened for HBsAg, anti-HBs, and anti-HBcIgG. Factors associated with hepatitis B seroprevalence, particularly living in rural areas, were analyzed with multivariate methods. The seroprevalence of HBsAg was 8.2% in the rural and 6.2% in the urban areas. There was a statistically significant difference between urban and rural regions in terms of HBsAg positivity (crude OR: 0.74; 95% CI: 0.55 - 0.98). Exposure to hepatitis B virus (HBV) increased with age both in urban and rural areas. Lower education level was also an important risk factor for hepatitis B seropositivity in urban areas (adjusted OR: 1.66; 95% CI: 1.26 - 2.19) but not in rural ones (adjusted OR: 0.77; 95% CI: 0.36 - 1.69). Familial jaundice history was a statistically significant risk factor for HBsAg positivity in rural areas (adjusted OR: 2.15; 95% CI: 1.30 - 3.56) but not in urban ones (adjusted OR: 1.48; 95% CI: 0.96 - 2.27). This study shows that the prevalence of HBV infection in the southeastern region of Turkey is intermediate among the levels reported for the European region of the World Health Organization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728984

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  20 in total

Review 1.  Prevalence and current therapy in chronic liver disorders.

Authors:  Muhammad Daniyal; Muhammad Akram; Rida Zainab; Naveed Munir; Aamir Sharif; Syed Muhammad Ali Shah; Bin Liu; Wei Wang
Journal:  Inflammopharmacology       Date:  2019-02-08       Impact factor: 4.473

2.  Chronic hepatitis B in children with or without malignancies: a 13-year follow-up.

Authors:  Merve Usta; Nafiye Urgancı; Zeynep Yıldız Yıldırmak; Sema Dogan Vural
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

3.  A Study on the Age-Related Changes in Hepatitis B and C Virus Serology.

Authors:  Ertugrul Guclu; Aziz Ogutlu; Oguz Karabay
Journal:  Eurasian J Med       Date:  2016-02

4.  Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders.

Authors:  Umut Kalyoncu; Ozlem Yonem; Meral Calguneri; Osman Ersoy; Omer Karadag; Ali Akdogan; Sule A Bilgen; Sedat Kiraz; Ihsan Ertenli; Yusuf Bayraktar
Journal:  Rheumatol Int       Date:  2008-11-27       Impact factor: 2.631

Review 5.  Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review.

Authors:  Mehlika Toy; Fatih Oguz Önder; Tanja Wörmann; A Mithat Bozdayi; Solko W Schalm; Gerard J Borsboom; Joost van Rosmalen; Jan Hendrik Richardus; Cihan Yurdaydin
Journal:  BMC Infect Dis       Date:  2011-12-12       Impact factor: 3.090

6.  Seroprevalence of hepatitis B and C among oncology patients in Turkey.

Authors:  Sukran Kose; Ali Olmezoglu; Ayhan Gozaydin; Gulfem Ece
Journal:  J Health Popul Nutr       Date:  2011-12       Impact factor: 2.000

7.  Hepatitis B surface antigen prevalence among 12,393 rural women of childbearing age in Hainan Province, China: a cross-sectional study.

Authors:  Yu Zhang; Weiming Fang; Lichun Fan; Xiaohui Gao; Yan Guo; Wenming Huang; Yukai Du
Journal:  Virol J       Date:  2013-01-18       Impact factor: 4.099

8.  Effect of routine Hepatitis B vaccination program in Southeast of Turkey? Comparing of the results of HBV DNA in terms of age groups for the years 2002 and 2012.

Authors:  Tuncer Ozekinci; Selahattin Atmaca; Tuba Dal
Journal:  Cent Eur J Immunol       Date:  2014-04-17       Impact factor: 2.085

9.  Eight-year seroprevalence of HBV, HCV and HIV in Diyarbakir training and research hospital.

Authors:  Mine Turhanoğlu; Arzu Onur; Fulya Bayındır Bilman; Zeynep Ayaydın; Gülseren Samancı Aktar
Journal:  Int J Med Sci       Date:  2013-09-12       Impact factor: 3.738

Review 10.  Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.

Authors:  Susan J M Hahné; Irene K Veldhuijzen; Lucas Wiessing; Tek-Ang Lim; Mika Salminen; Marita van de Laar
Journal:  BMC Infect Dis       Date:  2013-04-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.